Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |